chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient is self-referred for the evaluation of dizziness and weakness. Patient is a 32-year-old woman seen today in the office on an urgent basis for the evaluation of dizziness and weakness. She states she received the H1N1 vaccination on Tuesday, December 1. A little more than 24 hours later, on Thursday morning she woke up feeling extremely lightheaded, which lasted Thursday and all day on Friday. On Friday she went to the Urgent Care for their evaluation and she was given a prescription for meclizine, which she is yet to take. However, the dizziness seemed to get a little bit better. However, she started feeling weakness in her legs. Saturday she awoke with light headedness but felt weak in her entire body. By Saturday night, she felt really stiff in her body as well, which progressed to the neck and face. Yesterday she developed pain all through her body up to her neck. Her pain is a little better today but she still feels overall weak. It seems a little bit worse in her left arm. She has pain that is ongoing in the left upper quadrant that it has been evaluated by a doctor without any definitive etiology. In the past she has had left eye pain that comes and goes, not currently present. She does not report any worsening with changes in her position with the light headedness or with turning over in bed. Denies any diplopia, hearing loss or ringing in the ears. She dies report on both Saturday and Sunday nights when she was falling asleep, her legs gave a big jerk. She was concerned that it was only her legs and not her entire body.
4-5-21 11AM: PT STATES 'PAIN RT ARM (DESCRIBES DELTOID) WHEN HE PUTS HIS ARM ABOVE HIS HEAD.', SINCE 3-28-21. DENIES ANY PAIN TO SHOULDER OR ELBOW. HAS NOT USED HEAT, COOL PACK OR ANY PAIN MED TO RELIEVE PAIN. HAS NOT SEEN PCP.  NO CHANGE IN PAIN SINCE ONSET.
I ended up with pancreatitis after receiving my first dose. I went to Hospital. The day after my adverse event started, my husband called 911 and I was taken by ambulance to the hospital. They ran blood work. I was admitted for 2-3 days. When I was released, I followed up with my PCP and he put me on a low fat diet. He told me to not drink any alcohol, which I hardly drank anything but wine, once in a while. A week later, my PCP, did more blood work, and my levels lowered and they were not within range. I have now started having hot flashes again with nausea. I had blood work done last week and it is now perfect.
t99.5; blotchy erythematous red rash w/raised pin point areas-rt hand & wrist only;
administration of an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 48-year-old male patient who received HAV (Havrix) (batch number H4h53, expiry date 30th January 2023) for prophylaxis.   On 1st February 2023, the patient received Havrix. On 1st February 2023, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 1-Feb-2023 Reporter's comment: A nurse called to ask for information regarding the administration of an expired dose of Havrix to a patient. The reporter asked how to proceed with the patient. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired vaccine used.
Family of patient states that patient received 2 COVID vaccinations. Unknown manufacturer and dates of vaccines. Patient hospitalized after increased confusion
Member went to ER with extreme flu-like symptoms; vomiting, fever, passing out, dizziness, headaches and fatigue. Onset of symptoms started around 13:00 on 2/9/03 and progressed throughout the night.
The evening of the day I received the second dose of Pfizer, I noticed a ringing sound in my left ear that began very suddenly.  It's continuous and hasn't stopped since I received the second dose.
Hospitalized;  COVID-19 positive (9.9.21);  fully vaccinated  Admission Date: 9/10/2021 Discharge Date: 9/14/2021;  Discharge Disposition:  home health care DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness Acute respiratory failure with hypoxia COVID-19   HOSPITAL COURSE: Patient is a 68F who presents with vomiting, diarrhea, cough, generalized weakness since about 5-6 days PTA.  She has a history of ESRD on HD, HTN,  CML, hyperlipidemia.   She continued to feel considerably weak, so was tested for COVID on 09/08, which was positive.  She continued to have cough without production of sputum.  She did receive COVID vaccine (Moderna) in March and April.     On admission she was hypoxic to 84%, and required 2 L via NC.  CXR showed moderate cardiomegaly with central pulmonary vascular prominence and diffuse bilateral interstitial opacities. She was started on decadron 6 mg daily. Nephrology consulted and she underwent HD.   She remains stable on 2lpm NC. She denies further diarrhea and no fever.PT recommends home. She was discharged in stable condition on 9/14/21. She is to follow up with COVID at home program on discharge Pt on 9/14. Alert, NAD, Stable for discharge. In agreement with verbal instructions to follow up with her outpatient physicians
Joint aches mostly in knees, wrists, fingers and hip as well as mild muscle aches mainly in arms and shoulders. Chronic fatigue which led into depressing moods. OTC medicines with no avail.
Patient started to develop a rash on her check shortly after she received her vaccination and she was given 25mg of Benadryl to helps resolve the rash. HE waited around for about 45 mins and the rash began to clear up. The patient also stated that this happens frequently  and keeps Benadryl on hand for this reason. As the rash developed, she sent her son to her car to get some Benadryl; however we were able to give her a dose faster.
began having a fever of 101 degrees Fahrenheit; aches and chills; aches and chills; headache and all around feels horrible; headache and all around feels horrible; cough; scratchy throat; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6206), via an unspecified route of administration, administered in Left Arm on 10Mar2021 (age at the time of vaccination was 56 years) at 16:00 as dose 1, single for covid-19 immunisation. Medical history and family medical history relevant to AE(s) was reported as none. There were no concomitant medications. Additional Vaccines administered on same date of the pfizer suspect were reported as none. Prior Vaccinations (within 4 weeks) were reported as none. The reporter stated he had the Pfizer COVID Vaccine on 10Mar2021 which was Wednesday and then began having a fever of 101 degrees Fahrenheit, aches and chills, a headache and all around feels horrible, had a cough and scratchy throat and all of the listed symptoms began on Sunday 14Mar2021. The reporter stated all of the symptoms were ongoing but he believes he was turning a corner and these symptoms have improved and are starting to improve. The reporter clarified to state he still does have a fever but the chills and aches and pains are not as bad as they were an hour ago which was how long he was waiting on the phone for DSU. He stated he had not had any treatment for the reported symptoms. The reporter stated that he has not had his 2nd dose of the Pfizer COVID vaccine but it was scheduled. The AE(s) did not require a visit to Emergency Room. He just called the HCP and the HCP told him to take Ibuprofen or Tylenol for fever, aches and pains and to drink plenty of water. On 14Mar2021, the patient underwent lab tests and procedures which included body temperature: 101 degrees fahrenheit (began having a fever of 101 degrees Fahrenheit). This report is not related to a study or program. No investigation Assessment was reported. The outcome of the event began having a fever of 101 degrees Fahrenheit was not recovered. The outcome of the events headache and all around feels horrible, cough and scratchy throat was unknown. The outcome of the events aches and chills was recovering.  No follow-up attempts are possible. No further information is expected.
These started on Match 22, 2021. Red, swollen, hot, itchy, lump at injection site on left arm. Swollen, achy lymph node under left arm.  I still have these symptoms today, 3/24/3021, the swelling and itchiness is worse.   Mild headaches, tired and achy joints started the evening of the vaccination on 3/17/3021.  These are easing off.
This spontaneous report was received from a healthcare worker regarding two patients of unknown age and gender. There was no information patients pertinent medical history and drug reactions or allergies. On 17-MAR-2015, the patients were vaccinated with improperly stored doses of ZOSTAVAX (product lot#, expiry date, route, dose not reported). No adverse events were reported. There was no product quality complaint involved. The outcome of the events were unknown. Additional information has been requested.
Delayed menstrual cycle by 4 days, when started very painful and heavy. Much more clots than usual and lasting longer than usual. Uncomfortable enough to require rest. Still going heavy when it should be tapering off.?
Indication as potential COVID prevention; He mentioned that he did not know if this was a joint issue; The HCP's wife was frustrated that she was experiencing this for over a month; And it was a prolonged injection site reaction; patient began experiencing aching pain and disconfort on and around injection site; patient began experiencing aching pain and disconfort on and around injection site; This spontaneous report was received from a pharmacist and refers to a 73 year old female patient with sulfonamide  (BACTRIM) allergy, nitrofurantoin (MACRODANTIN) allergy  and Gastrointestinal upset. Concomitant therapies included herbs (unspecified), levothyroxine sodium(SYNTHROID) and raloxifene hydrochloride(EVISTA).  Information regarding the patient's medical history and historical drugs was not provided.  On 09-SEP-2020 , the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live rHA (recombinant human albumin) (M-M-R II) lot # S023654, expiration date 30-JUL-2021, subcutaneously in her left arm for potential COVID 19 prevention (prophylaxis) (product use in unapproved indication).  On 11-SEP-2020, patient began experiencing aching pain and discomfort on and around injection site (injection site pain and injection site discomfort).  On an unknown date in October 2020, the patient  experienced a prolonged injection site reaction, she was frustrated that she was experiencing this for over a month(frustration tolerance decreased) and her husband mentioned that he did not know if this was a joint issue (Arthropathy).   On 05-OCT-2020, the patient sought medical attention due to the events.   The outcome of injection site pain, frustration tolerance decreased, injection site reaction, arthropathy and injection site discomfort was unknown.     The causality between the events and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) was not provided.
Eyes rolling in the  back of head, bobbing of head, eye lids blinking very fast. Happened 3 times in one day. One at 1:15 PM, second at 5 PM, and than third time at 8:30 PM on 01/23/2020
COVID 19 treatment; COVID 19 treatment; Dose 3: Moderna, Dose 4: Pfizer; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Oct2022 as dose 4 (booster), single (Lot number: GJ2524) at the age of 46 years, in right arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 25Mar2021 as dose 1, single (Lot number: ER8732), in right arm and on 14Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 10Dec2021 as dose 3 (booster), single (Lot number: 032h21a), in right arm for COVID-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa" (unspecified if ongoing). Concomitant medications included: FLUTICASONE PROPRIONATE, start date: 01Nov2021. Past drug history included: Amoxicillin, reaction: "Known allergies: amoxicillin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 13Oct2022, outcome "unknown", described as "Dose 3: Moderna, Dose 4: Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 08Aug2023 to 13Aug2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Congestion, Hypoxia, SOB, Tachycardia, Weakness. Started on O2 @ 3L, HOB elevated, Tylenol supp
Patient is a 15 yo female who received a COVID-19 booster dose. The patient is 4 days away from turning 16. Patient has received the third dose which hasn't yet been approved for 15 year old. The patient's parent was contacted and made aware of the mistake by the administering pharmacist. The patient was okay with it since they are almost 16. The patient reported no adverse events during the call. Patient's PCP was also contacted and left a message for.
Patient reported headaches to PCP since vaccination.  Presented to hospital with visual hallucinations.  Her neuro status continued to deteriorate.  She was reporting left-sided visual field deficits and left-sided weakness, although her neuro exam was inconsistent, and waxed and waned.  She eventually became fairly rigid, would not flinch if you peeled open her eyes to look at her pupils, and eventually became verbally unresponsive.  Her vital signs were stable throughout all of this and she was able to maintain her own airway.  Eventually diagnosed with autoimmune encephalopathy and treated with high dose steroids after neurology and psychiatry consultation.  She had rapid clinical improvement after steroids.
Patient came to facility to receive their second dose of COVID-19 mRNA vaccine. After administration, the clinician realized they had administered the incorrect mRNA vaccine as the patient's vaccine card showed their first dose was a Moderna dose. Clinician notified the patient of the error. Clinician documented on the patient's vaccine card that the second COVID-19 dose was Pfizer
The pt developed hives after the 2nd dose of the Hep B vaccine. Approximately 21 hours post vax. The hives were confined to the upper torso front and back.
BODY CONVULSIONS FROM CHILLS; BODY ACHES; TEARY EYES; RAPID BREATHING; STUFFY NOSE; CHILLS AND CHATTERING TEETH; PRESSURE HEADACHE; FEVER WITH CHILLS; SORE MUSCLE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown) dose was not reported, 1 total, administered on 29-APR-2021 at around 11:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 29-APR-2021, the patient experienced body convulsions from chills, body aches, teary eyes, rapid breathing, stuffy nose, pressure headache, chills and chattering teeth, fever with chills and sore muscle. On 29-APR-2021 at around 15:00, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body convulsions from chills, body aches, teary eyes, rapid breathing, stuffy nose, chills and chattering teeth, and sore muscle, and was recovering from fever with chills, and pressure headache. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210460597-covid-19 vaccine ad26.cov2.s- body convulsions from chills. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Syncope, light headedness, shortness of breath, nausea, hypotension. Symptoms resolved within half an hour.
Vomited; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomited) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03LL20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VOMITING (Vomited). At the time of the report, VOMITING (Vomited) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Patient received all 3 vaccines at the same visit. Was fine for the remainder of that day. Symptoms began the following morning around 10:00. Patient experienced chills and shaking, took a nap in recliner for an hour then experienced severe weakness when he woke up. Was barely able to walk to the bathroom due to weakness he experienced. Wife called EMS as she as concerned about his status. Transported to hospital via ambulance where is currently an inpatient receiving treatment. ER physician feels his condition is likely due to receiving vaccines simultaneously.
A-fib; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old male patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Flu shot (DOSE NUMBER UNKNOWN, SINGLE, Clarifies he got his Flu shot 7 weeks ago.), administration date: Sep2023. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "A-fib". The event "a-fib" required physician office visit. The patient had all the vaccines, he's always gotten Pfizer. His only question is, because of his age and he has A-fib, which is under control. He's being seen by a Cardiologist, stating everything is fine. Confirmed he has not received the COVID-19 Vaccine for 2023-2024 yet. Caller provided that he had no problems with the COVID-19 Vaccines he has taken. However, when mentioning he has A-fib, caller did not state if the A-fib was diagnosed prior to or after the COVID-19 Vaccines he received.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
She had rotator cuff damage in her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ROTATOR CUFF SYNDROME (She had rotator cuff damage in her shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ROTATOR CUFF SYNDROME (She had rotator cuff damage in her shoulder). At the time of the report, ROTATOR CUFF SYNDROME (She had rotator cuff damage in her shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product use was reported.  The reporter stated that the patient experienced the same thing after their vaccinations. The patient three months after their shot had rotator cuff damage in their shoulder, but never had previous history of it either.  No treatment information was provided.
This report describes the occurrence of the vision being affected in a 39 year old female who received Hep-B vaccine recombinant (Engerix-B). The vaccinee required corrective eye lenses at the time of IZ. Concurrent medications were not specified. On 12/7/01, the vaccinee received her 1st injection of Engerix-B. That same day, the vision in  her left eye was affected (NOS). Two days later, she experienced the same symptoms. The vaccinee reportedly changed her eye glass prescription after this event. As of 2/5/01, the event was "partially resolved". On 1/18/02, the vaccinee received her 2nd injection of Engerix-B. There were no reported adverse events related to this injection.
constant chest pain; Heart palpitations; Fatigue; This is a spontaneous report from a contactable consumer reporting for husband. This report is not related to a study or programme. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced constant chest pain, heart palpitations, fatigue on an unspecified date. Reporter stated that patient received the vaccine on the 09 and he had this constant chest pain and heart palpitations and fatigue, and he was expensing on the EB. When probed for the confirmation of vaccine name as Pfizer COVID-19 Vaccine, Reporter stated that he had that since he got the first Pfizer COVID vaccine. Reporter was informed about the role of Pfizer drug safety. Reporter stated that she just wanted someone to report it and know what she needed to do from there. Reporter asked what Pfizer would recommend that they do with these adverse side effects. Reason for no lot number of COVID-19 Vaccine was caller unwilling to complete the report. Further probing could not be done as the reporter was unwilling to complete the report. Hence, limited information available over the call. Clinical outcome of events was unknown.  Information about lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.